XML 18 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Revenues:      
Revenues $ 20,653 $ 25,186 $ 26,353
Expenses      
Cost of products sold 1,142 2,297
Research and development 84,888 66,962 61,008
Selling, general and administrative 29,514 13,933 11,253
Royalty 471 560 402
Total operating expenses 114,873 82,597 74,960
Loss from operations (94,220) (57,411) (48,607)
Interest and other income 2,252 1,015 793
Interest expense (9,176) (8,565) (6,487)
Loss on foreign currency derivative (108) (821) (843)
Net loss (101,252) (65,782) (55,144)
Unrealized (loss) gain on available for sale investments (54) (231) 194
Net comprehensive loss $ (101,306) $ (66,013) $ (54,950)
Basic and diluted net loss per common share (in dollars per share) $ (0.98) $ (0.78) $ (0.75)
Weighted average shares outstanding (in shares) 103,185 84,451 73,699
Product [Member]      
Revenues:      
Revenues $ 1,501 $ 2,269
Royalty [Member]      
Revenues:      
Revenues 6,101 10,543 9,682
Collaborative and Other Research and Development [Member]      
Revenues:      
Revenues $ 14,552 $ 13,142 $ 14,402